SCHEMBL770696

SCHEMBL770696

O=C(O)CCC(=O)N1CCC2CCCC=C2C1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
CNR1 P21554 2/20 0.36
MAPK1 P28482 2/20 0.36
ALDH1A1 P00352 4/20 0.35
POLB P06746 2/20 0.35
HPGD P15428 3/20 0.35
HSD17B10 Q99714 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.34
USP2 O75604 1/20 0.34
KDM4E B2RXH2 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
RECQL P46063 1/20 0.34
EPHX1 P07099 1/20 0.34
EPHX2 P34913 1/20 0.34
ITGB3 P05106 1/20 0.34
ITGA2B P08514 1/20 0.34
LMNA P02545 1/20 0.33
MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL771656 0.94 MAPK1 (0.36) KMT2AMAPK1ALDH1A1POLBHPGD
SCHEMBL770381 0.92 ITGB3 (0.41) MAPK1ALDH1A1POLBHPGDSMN1; SMN2
SCHEMBL770768 0.92 ITGB3 (0.41) MAPK1ALDH1A1HPGDSMN1; SMN2EPHX1
SCHEMBL771900 0.89 ATM (0.39) MEN1KMT2AALDH1A1HPGDHSD17B10
SCHEMBL770401 0.89 LMNA (0.39) MEN1KMT2AMAPK1ALDH1A1HPGD
SCHEMBL769789 0.89 NPC1 (0.42) MEN1KMT2AMAPK1ALDH1A1POLB
SCHEMBL769773 0.87 HDAC3 (0.35) MAPK1ALDH1A1POLBHPGDSMN1; SMN2
SCHEMBL770666 0.87 RBP4 (0.44) CNR1ALDH1A1POLBSMN1; SMN2ITGB3
SCHEMBL770939 0.86 NPC1 (0.49) MEN1KMT2AALDH1A1HPGDSMN1; SMN2
SCHEMBL770744 0.86 SMYD3 (0.37) MAPK1ALDH1A1POLBHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2439202-B1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 SALVAT LAB SA (ES) 2016-04-20 EP disclosed
US-8524894-B2 Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1 LABORATORIOS SALVAT, S.A. (ES) 2013-09-03 US disclosed
US-20120071466-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 LABORATORIOS SALVAT, S.A. (ES) 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120071466-A1 INHIBITOR COMPOUNDS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 HSD11B1, HSD17B1, HSD11B2 MEN1 823/4885KMT2A 3893/4885CNR1 1859/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.